Your session is about to expire
← Back to Search
Early Follicular Phase (EFP) for Women's Health
N/A
Waitlist Available
Research Sponsored by Southern Illinois University Edwardsville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 weeks
Awards & highlights
Study Summary
This trial will analyze how different phases of the menstrual cycle affect a woman's response to resistance training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in estrogen concentrations
Change in progesterone concentrations
Secondary outcome measures
Cardiorespiratory Fitness
Changes in diet
Fat mass (kg)
+5 moreSide effects data
From 2010 Phase 2 trial • 167 Patients • NCT0011215166%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T
Trial Design
4Treatment groups
Experimental Treatment
Group I: Late Luteal Phase (LLP)Experimental Treatment1 Intervention
Group II: Late Follicular Phase (LFP)Experimental Treatment1 Intervention
Group III: Early Luteal Phase (ELP)Experimental Treatment1 Intervention
Group IV: Early Follicular Phase (EFP)Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1190
Find a Location
Who is running the clinical trial?
Southern Illinois University EdwardsvilleLead Sponsor
5 Previous Clinical Trials
52 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger